Argatroban Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
- 99S4096582
- 92 Pages
- November 2020
- Healthcare
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary
.
The global Argatroban market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Argatroban market segmented into
Heparin-induced thrombocytopenia (HIT)
Argatroban Injection
Based on the end-use, the global Argatroban market classified into
Heparin-induced thrombocytopenia (HIT)
Percutaneous Coronary Intervention
Cerebral arterial thrombosis
Based on geography, the global Argatroban market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
Pfizer
SANDOZ
GlaxoSmithKline
fresenius-kabi
Eagle Pharmaceuticals
Mitsubishi Tanabe Pharma
Teva Pharmaceutical Industries
WEST-WARD
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL ARGATROBAN INDUSTRY
2.1 Summary about Argatroban Industry
2.2 Argatroban Market Trends
2.2.1 Argatroban Production & Consumption Trends
2.2.2 Argatroban Demand Structure Trends
2.3 Argatroban Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Argatroban Powder
4.2.2 Argatroban Injection
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Heparin-induced thrombocytopenia (HIT)
4.3.2 Percutaneous Coronary Intervention
4.3.3 Cerebral arterial thrombosis
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Argatroban Powder
5.2.2 Argatroban Injection
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Heparin-induced thrombocytopenia (HIT)
5.3.2 Percutaneous Coronary Intervention
5.3.3 Cerebral arterial thrombosis
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Argatroban Powder
6.2.2 Argatroban Injection
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Heparin-induced thrombocytopenia (HIT)
6.3.2 Percutaneous Coronary Intervention
6.3.3 Cerebral arterial thrombosis
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Argatroban Powder
7.2.2 Argatroban Injection
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Heparin-induced thrombocytopenia (HIT)
7.3.2 Percutaneous Coronary Intervention
7.3.3 Cerebral arterial thrombosis
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Argatroban Powder
8.2.2 Argatroban Injection
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Heparin-induced thrombocytopenia (HIT)
8.3.2 Percutaneous Coronary Intervention
8.3.3 Cerebral arterial thrombosis
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Argatroban Powder
9.2.2 Argatroban Injection
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Heparin-induced thrombocytopenia (HIT)
9.3.2 Percutaneous Coronary Intervention
9.3.3 Cerebral arterial thrombosis
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Pfizer
10.1.2 SANDOZ
10.1.3 GlaxoSmithKline
10.1.4 fresenius-kabi
10.1.5 Eagle Pharmaceuticals
10.1.6 Mitsubishi Tanabe Pharma
10.1.7 Teva Pharmaceutical Industries
10.1.8 WEST-WARD
10.2 Argatroban Sales Date of Major Players (2017-2020e)
10.2.1 Pfizer
10.2.2 SANDOZ
10.2.3 GlaxoSmithKline
10.2.4 fresenius-kabi
10.2.5 Eagle Pharmaceuticals
10.2.6 Mitsubishi Tanabe Pharma
10.2.7 Teva Pharmaceutical Industries
10.2.8 WEST-WARD
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
1.Table Argatroban Product Type Overview
2.Table Argatroban Product Type Market Share List
3.Table Argatroban Product Type of Major Players
4.Table Brief Introduction of Pfizer
5.Table Brief Introduction of SANDOZ
6.Table Brief Introduction of GlaxoSmithKline
7.Table Brief Introduction of fresenius-kabi
8.Table Brief Introduction of Eagle Pharmaceuticals
9.Table Brief Introduction of Mitsubishi Tanabe Pharma
10.Table Brief Introduction of Teva Pharmaceutical Industries
11.Table Brief Introduction of WEST-WARD
12.Table Products & Services of Pfizer
13.Table Products & Services of SANDOZ
14.Table Products & Services of GlaxoSmithKline
15.Table Products & Services of fresenius-kabi
16.Table Products & Services of Eagle Pharmaceuticals
17.Table Products & Services of Mitsubishi Tanabe Pharma
18.Table Products & Services of Teva Pharmaceutical Industries
19.Table Products & Services of WEST-WARD
20.Table Market Distribution of Major Players
21.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
22.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
23.Table Global Argatroban Market Forecast (Million USD) by Region 2021f-2026f
24.Table Global Argatroban Market Forecast (Million USD) Share by Region 2021f-2026f
25.Table Global Argatroban Market Forecast (Million USD) by Demand 2021f-2026f
26.Table Global Argatroban Market Forecast (Million USD) Share by Demand 2021f-2026f
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
